Part D Conclusions G0498-01

Year: 2013

Conclusions on the potential environmental impact from the release or the placing on the market of genetically modified organisms, re G0498-01

G0498-01 Inspector's Report

Year: 2013

All documentation submitted in respect of this notification was taken into consideration by the EPA Inspector in her report to the Board of the Agency

Board Minute Extract of 25 June 2013

Year: 2013

An extract from the minutes of the EPA Board Meeting of 25 June 2013 at which the Centre for Cellular and Molecular Therapeutics' notification seeking consent to carry out a clinical trial at St James's Hospital Dublin was discussed

G0498-01 Consent Conditions

Year: 2013

G0498-01 Consent Condition issued to The Centre for Cellular and Molecular Therapeutics at the Children's Hospital of Philadelphia, USA, on 3 July 2013 for a clinical trial using a Genetically Modified Organism (GMO) at St. James's Hospital Dublin

Summary Notification Information Format G0498-01

Year: 2013

Summary Notification Information Format for proposed Clinical Trial G0498-01

Response from Teagasc 14 June 2012

Year: 2013

Correspondence from Teagasc regarding 4 April 2012 and 23 May 2012 requests for further information

Response from Teagasc 11 April Part 2

Year: 2013

Teagasc's response, dated 11 April 2012, to EPA's request for further information, Part 2

EPA Letter to Teagasc issued May 2012

Year: 2013

Letter to Teagasc in May 2012 re GM Field Trial

Response from Teagasc 11 April Part 1

Year: 2013

Teagasc's response, dated 11 April 2012, to EPA's request for further information, Part 1

EPA letter to Teagasc issued April 2012

Year: 2013

EPA letter to Teagasc, issued 4 April 2012, requesting further information

How to make a representation

Year: 2013

The following information note sets out how persons may make a representation to the EPA in response to a newspaper notice under Part II of the GMO (Deliberate Release) Regulations, S.I. No. 500 of 2003.

EPA Letter to Teagasc issued March 2012

Letter to Teagasc from EPA requesting further information, January 2013

Year: 2013

Letter to Teagasc in March 2012 re GM Potato Field Trial

Newspaper Notice for field trial GM potatoes

Year: 2013

The following is the text of the newspaper notice published by Teagasc in the Irish Independent newspaper on 29 February 2012 in accordance with the requirements of Article 15 of the GMO (Deliberate Release) Regulations, S.I. No 500 of 2003

Summary notification information format (SNIF) on Teagasc notification for performance of GM potato field study

Year: 2013

This document outlines a summary of the notification (application) received from Teagasc for performance of the field study with GM blight resistant potatoes.

Teagasc Notification for field study on GM potatoes

Year: 2013

The document constitutes the notification (application) received from Teagasc, Oak Park, Carlow on 27 February 2012 seeking a consent and to carry out a field study with GM blight resistant potatoes

GMO Register G0469-01

Year: 2013

GMO Register G0469-01

Draft Consent Conditions

Year: 2013

Draft Consent for Notification No. B/IE/12/01 Teagasc, Oak Park, Co Carlow - the deliberate release of GM potato line (with improved resistance to late potato blight) into the environment for purposes other than for placing on the market (field trials)

Extract from the minutes of the EPA Board meeting of 10 July 2012

Year: 2013

An extract from the minutes of the EPA Board meeting of 10 July 2012, at which Teagasc's notification seeking consent to carry out a GM potato field trial at Oak Park, Co Carlow, was discussed.

Consent for Notification No. B/IE/12/01 - G0469-01 Decision

Year: 2013

Consent to a deliberate release of GM potato line (with improved resistance to late potato blight) into the environment for purposes other than for placing on the market (field trials)

G0469-01 Inspector's Report and Addenda

Year: 2013

Teagasc GM Field Trial Inspector's Report and Addenda: All documentation submitted in respect of this notification, including valid representations made by members of the public, were taken into consideration by the EPA Inspector in her report and corresponding addenda.

Pagination